--- title: "Veeva moves AI to flat fees, with Vault AI at 10% of the Vault subscription, and no AI dollar yet" description: "The invoice no longer rises with agent work: Vault AI is 10 percent of the Vault subscription with unlimited use, and the compute cost lands on Veeva. Wells Fargo raised its target to $400 on AI growth today anyway, and December 3 results are the first place an AI dollar could appear." publisher: "The Inference" section: "Applications" published: 2026-11-11T15:48:28.164Z modified: 2026-11-11T15:48:28.164Z canonical: https://theinference.org/article/veeva-moves-ai-to-flat-fees-with-vault-ai-at-10-of-the-vault-subscription-and-no-ai-dollar-yet language: en keywords: "Veeva Systems, AI Pricing, Analyst Calls, Life Sciences Software, Healthcare AI" --- # Veeva moves AI to flat fees, with Vault AI at 10% of the Vault subscription, and no AI dollar yet > The invoice no longer rises with agent work: Vault AI is 10 percent of the Vault subscription with unlimited use, and the compute cost lands on Veeva. Wells Fargo raised its target to $400 on AI growth today anyway, and December 3 results are the first place an AI dollar could appear. ## A flat fee takes the meter off the agents [Veeva](https://theinference.org/markets/companies/veeva-systems), which sells cloud software to the drug industry, has settled how it charges for AI, and the settlement caps what AI can add to revenue. At its [European MedTech Summit](https://www.technologynetworks.com/tn/blog/inside-veevas-medtech-summit-making-more-time-for-science-with-ai-418134), before 75 medtech companies, Veeva MedTech president Seth Goldenberg said Veeva is "moving away from a token model to a fixed fee model that's based on a user's Vault subscription," calling per-token billing "not sustainable for the world" [1]. The structure was already on record from the [November 5 investor day](https://finance.yahoo.com/technology/ai/articles/veeva-systems-sticks-6-billion-021432104.html) [3][2]. Vault AI, the assistant inside [the Vault applications](https://www.veeva.com/products/vault-platform/) where drugmakers run clinical, regulatory and quality work [3], is an optional 10 percent of the applicable Vault subscription, with unlimited use, and Falcon, the agents that run clinical, regulatory and safety workflows end to end, sells as an annual license priced by capability and customer size [2]. Nothing in it rises with usage; the only thing that scales with agent work is Veeva's compute bill. ## The $6 billion plan already leaves the AI out The 2030 target Veeva reaffirmed that day, a [$6 billion annual revenue run rate](https://theinference.org/article/veeva-reaffirms-6-billion-2030-target-says-quarter-will-meet-or-exceed-guidance) against roughly $3.7 billion in the July quarter, counts only products it already sells; Falcon, Vault AI and Aspen, its customer-relationship-management push outside drugs, are excluded, and none carries a financial target [4]. Falcon went into early adoption this month [1] with a few customers live; chief executive Peter Gassner expects revenue only next year and declined to size it: "We have to make these things work first" [2]. No filing has shown a dollar of AI revenue [4]. ## Wells Fargo's $400 prices an AI line the flat fee caps [Wells Fargo](https://theinference.org/markets/companies/wells-fargo) analyst Stan Berenshteyn [lifted his target to $400 from $330](https://www.streetinsider.com/Analyst+Comments/Veeva+Systems+%28VEEV%29+PT+Raised+to+%24400+at+Wells+Fargo/27325882.html) today, on AI growth [5][6]. That tops the eight banks that raised after the investor day, on a stock already up 37 percent this year [4]. *Chart: **Wells Fargo's $400 sits above every post-investor-day target** Bar chart of Veeva price targets in dollars: Wells Fargo at $400 highest, then Jefferies $375, RBC $365, BTIG, Needham and Truist at $360, Stifel $340, UBS and Evercore ISI at $325, with reference lines at the November 9 close of $306.40 and the 29-analyst consensus of $323.07.* *Price targets for Veeva (NYSE: VEEV), US dollars: eight raises on November 6, 2026, and Wells Fargo's raise on November 11, against the November 9 close and the 29-analyst consensus. Sources: The Inference; StreetInsider. [4][5]* ## December 3 is the first place an AI dollar can show The customer story is real and slower than the repricing. Roche, the world's fifth-largest drugmaker and an early Falcon adopter, counts [three quarters of its staff as active AI users](https://diginomica.com/ai-and-life-sciences-how-roche-making-regulatory-compliance-faster-and-more-efficient-veeva), yet its regulatory operations lead, Joanne Byrne, insists basics come first: cleaner data, fewer clicks, then agentic AI [7]. Goldenberg's own pace marker is humbler: twenty years into cloud, over half of all software still runs on premises [1]. The flat fee is still the right design. Predictable cost is what lets a regulated industry turn agents loose without watching a meter, and Veeva is doing the work of wiring agents into daily workflow, which deserves to be paid in revenue. When Veeva reports the October quarter on December 3, a quarter it has affirmed will meet or exceed guidance [4], the number to ask for is what the flat fee earns per customer. Until that number exists, the $400 rests on a usage curve the invoice refuses to draw [4]. ## Takeaway Veeva has fixed its AI pricing so nothing scales with usage, and the $6 billion 2030 plan counts none of it; December 3 is the first place an AI dollar can appear. ## Sources 1. [Technology Networks, Inside Veeva's MedTech Summit: Making More Time for Science With AI, 11 November 2026](https://www.technologynetworks.com/tn/blog/inside-veevas-medtech-summit-making-more-time-for-science-with-ai-418134) 2. [MarketBeat via Yahoo Finance, Veeva Systems Sticks to $6 Billion Revenue Goal as AI Expands Its Market Opportunity, 5 November 2026](https://finance.yahoo.com/technology/ai/articles/veeva-systems-sticks-6-billion-021432104.html) 3. [Veeva Systems, Veeva Vault Platform product page, accessed 11 November 2026](https://www.veeva.com/products/vault-platform/) 4. [The Inference, Veeva reaffirms $6 billion 2030 target, says quarter will meet or exceed guidance, 10 November 2026](https://theinference.org/article/veeva-reaffirms-6-billion-2030-target-says-quarter-will-meet-or-exceed-guidance) 5. [StreetInsider, Veeva Systems (VEEV) PT Raised to $400 at Wells Fargo, 11 November 2026](https://www.streetinsider.com/Analyst+Comments/Veeva+Systems+%28VEEV%29+PT+Raised+to+%24400+at+Wells+Fargo/27325882.html) 6. [Investing.com, Wells Fargo raises Veeva Systems stock price target on AI growth, 11 November 2026](https://www.investing.com/news/analyst-ratings/wells-fargo-raises-veeva-systems-stock-price-target-on-ai-growth-93CH-5018241) 7. [diginomica, AI and Life Sciences: how Roche is making regulatory compliance faster and more efficient with Veeva, 10 November 2026](https://diginomica.com/ai-and-life-sciences-how-roche-making-regulatory-compliance-faster-and-more-efficient-veeva) --- Veeva moves AI to flat fees, with Vault AI at 10% of the Vault subscription, and no AI dollar yet — The Inference. Canonical: https://theinference.org/article/veeva-moves-ai-to-flat-fees-with-vault-ai-at-10-of-the-vault-subscription-and-no-ai-dollar-yet